Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...

Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...

Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.

A specialist can diagnose bladder cancer using a variety of tests. “Bladder cancer can be diagnosed through a combination of ...

Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms ...

The trial showed a 'clinically meaningful' and 'statistically significant' improvement when treated with therapy plus BCG, ...

A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...

Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.

The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.